From Our Partners · Video

Interview with Kavita Ramalingam Iyer from Merck Sharp & Dohme

Anne Montgomery, Editor In Chief, BioProcess International Magazine, recently sat down with Kavita Ramalingam Iyer, PH.D., Associate Director, Global Regulatory Affairs and Clinical Safety – CMC Vaccines at Merck Sharp & Dohme at BioTechWeek in Boston in September to discuss BPOG’s closed system and regulatory interaction work groups.

Trending on Xconomy